[go: up one dir, main page]

DE60311990D1 - Verfahren zur herstellung eines virus inaktivierten thrombin präparates - Google Patents

Verfahren zur herstellung eines virus inaktivierten thrombin präparates

Info

Publication number
DE60311990D1
DE60311990D1 DE60311990T DE60311990T DE60311990D1 DE 60311990 D1 DE60311990 D1 DE 60311990D1 DE 60311990 T DE60311990 T DE 60311990T DE 60311990 T DE60311990 T DE 60311990T DE 60311990 D1 DE60311990 D1 DE 60311990D1
Authority
DE
Germany
Prior art keywords
virus
inactived
producing
thrombin preparation
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60311990T
Other languages
English (en)
Other versions
DE60311990T2 (de
Inventor
Caroline Connolly
Christopher Hardway
David Evans
Peter Feldman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NHS Blood and Transplant
Original Assignee
NHS Blood and Transplant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NHS Blood and Transplant filed Critical NHS Blood and Transplant
Publication of DE60311990D1 publication Critical patent/DE60311990D1/de
Application granted granted Critical
Publication of DE60311990T2 publication Critical patent/DE60311990T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60311990T 2002-07-10 2003-07-07 Verfahren zur herstellung eines virus inaktivierten thrombin präparates Expired - Lifetime DE60311990T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0216002.6A GB0216002D0 (en) 2002-07-10 2002-07-10 Process and composition
GB0216002 2002-07-10
PCT/GB2003/002942 WO2004007707A1 (en) 2002-07-10 2003-07-07 Process for producing a virus-inactivated thrombin preparation

Publications (2)

Publication Number Publication Date
DE60311990D1 true DE60311990D1 (de) 2007-04-05
DE60311990T2 DE60311990T2 (de) 2007-11-08

Family

ID=9940204

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60311990T Expired - Lifetime DE60311990T2 (de) 2002-07-10 2003-07-07 Verfahren zur herstellung eines virus inaktivierten thrombin präparates

Country Status (19)

Country Link
US (1) US8435779B2 (de)
EP (1) EP1520018B1 (de)
JP (1) JP4445386B2 (de)
AT (1) ATE354648T1 (de)
AU (1) AU2003244858B2 (de)
BR (1) BRPI0312522B8 (de)
CA (1) CA2491718C (de)
CY (1) CY1107632T1 (de)
DE (1) DE60311990T2 (de)
EC (1) ECSP055586A (de)
ES (1) ES2282644T3 (de)
GB (1) GB0216002D0 (de)
IL (3) IL165989A0 (de)
MX (1) MXPA05000393A (de)
NO (1) NO20050090L (de)
NZ (1) NZ537502A (de)
PL (1) PL208219B1 (de)
PT (1) PT1520018E (de)
WO (1) WO2004007707A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1778301A2 (de) * 2004-06-29 2007-05-02 Reliance Life Sciences Pvt., Ltd. Verfahren zur verbesserung virensicherer biologischer flüssigkeiten
EP1685852A1 (de) * 2005-02-01 2006-08-02 Fondation pour la Recherche Diagnostique Set von Einwegbeuteln zur Virusinaktivierung von biologischen Fluids
US20060270015A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
CN101233229B (zh) * 2005-07-29 2013-05-01 雅培实验室有限公司 制备消毒的胰酶粉末的方法
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
RU2466187C2 (ru) * 2006-05-22 2012-11-10 Эбботт Продактс Гмбх Способ выделения и определения вирусной нагрузки в образце панкреатина
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US7774628B2 (en) * 2006-05-25 2010-08-10 Foundry Networks, Inc. Enabling/disabling power-over-ethernet software subsystem in response to power supply status
KR20100134078A (ko) * 2008-04-16 2010-12-22 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 트롬빈 고정화 생체 흡수성 시트 제제의 제조방법
JP5442310B2 (ja) * 2009-04-23 2014-03-12 旭化成メディカル株式会社 トロンビン溶液の調製方法
AU2015252061A1 (en) * 2009-07-31 2015-11-19 Baxalta GmbH Method for Purifying Recombinant ADAMTS13 and Other Proteins and Compositions Thereof
US8945895B2 (en) * 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
SE1050124A1 (sv) * 2010-02-08 2011-08-09 Linkoping Biocontrols Ab Stabil lösning
CN102357259A (zh) 2011-07-28 2012-02-22 王珊珊 一种生物蛋白海绵及其制备方法
KR20150027060A (ko) * 2012-05-31 2015-03-11 에이전시 포 사이언스, 테크놀로지 앤드 리서치 다중 모드의 기능성들을 갖는 입자들로 면역글로불린 g 조제물들의 크로마토그래피 정제
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
CN113754757B (zh) * 2021-07-01 2024-06-14 华兰生物工程股份有限公司 一种人纤维蛋白原的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
IE73210B1 (en) * 1990-01-24 1997-05-07 Warner Lambert Co Process for the production of thrombin and high purity thrombin preparation thereby obtained
ATE177781T1 (de) * 1990-02-20 1999-04-15 Baxter Int Gereinigtes, virusfreies menschliches thrombin
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
DE4137996A1 (de) 1991-11-19 1993-05-27 Behringwerke Ag Verfahren zur herstellung eines virussicheren thrombinkonzentrates
AT397390B (de) 1992-04-06 1994-03-25 Immuno Ag Verfahren zur spaltung von proteinen
GB9503750D0 (en) * 1995-02-24 1995-04-12 Common Services Agency Thrombin preparation
AT500670A1 (de) 1999-05-19 2006-02-15 Bio & Bio Licensing Sa Arzneimittel zur lokalen anwendung
US6245548B1 (en) * 2000-03-09 2001-06-12 American National Red Cross Activation of pure prothrombin to thrombin with about 30% to about 40% sodium citrate
DE10012732A1 (de) 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
IL136552A (en) 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material

Also Published As

Publication number Publication date
PT1520018E (pt) 2007-04-30
CA2491718A1 (en) 2004-01-22
ECSP055586A (es) 2005-07-06
MXPA05000393A (es) 2005-07-22
EP1520018A1 (de) 2005-04-06
ATE354648T1 (de) 2007-03-15
PL208219B1 (pl) 2011-03-31
EP1520018B1 (de) 2007-02-21
JP2005532073A (ja) 2005-10-27
BR0312522A (pt) 2005-04-19
BRPI0312522B8 (pt) 2021-05-25
ES2282644T3 (es) 2007-10-16
JP4445386B2 (ja) 2010-04-07
US8435779B2 (en) 2013-05-07
WO2004007707A1 (en) 2004-01-22
GB0216002D0 (en) 2002-08-21
IL165989A0 (en) 2006-01-15
PL374747A1 (en) 2005-10-31
DE60311990T2 (de) 2007-11-08
NZ537502A (en) 2007-12-21
CA2491718C (en) 2013-10-22
US20060134769A1 (en) 2006-06-22
AU2003244858B2 (en) 2008-01-31
AU2003244858A1 (en) 2004-02-02
IL165989A (en) 2010-11-30
NO20050090L (no) 2005-04-08
CY1107632T1 (el) 2013-04-18
IL201146A (en) 2011-05-31
BRPI0312522B1 (pt) 2019-01-02

Similar Documents

Publication Publication Date Title
DE60311990D1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
DE50312217D1 (de) Verfahren zur herstellung von 1-olefinen durch katalytische spaltung von 1-alkoxyalkanen
ATE529409T1 (de) Verfahren zur herstellung von kristallinen aripiprazolformen
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
DE502004003625D1 (de) Verfahren zur herstellung von polyisobutenen
DE60042035D1 (de) Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen
ATE404577T1 (de) Verfahren zur herstellung von eplerenon
ATE542810T1 (de) Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton
ATE335745T1 (de) Verfahren zur herstellung von protease hemmenden zwischenprodukten
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DE602006013688D1 (de) Neues verfahren zur herstellung von thoc
DE602004003037D1 (de) Verfahren und zwischenprodukte für die herstellung von emtricitabin
ATE325794T1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
ATE341558T1 (de) Verfahren zur herstellung von topiramate
DE50103009D1 (de) Verfahren zur herstellung von 2-alkyl-3-chlorphenolen
DE602004031727D1 (de) Neues verfahren und zwischenprodukte zur herstellung von 19-nor-steroiden
ATE425143T1 (de) Verfahren zur herstellung von indolen
ATE451345T1 (de) Verfahren zur herstellung von optisch aktiven 3- phenylpropionsäurederivaten und folgeprodukte davon
ATE466847T1 (de) Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat
ATE537160T1 (de) Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
DE50203529D1 (de) Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte
ATE325111T1 (de) Verfahren zur herstellung von 15-pentadecanolid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1520018

Country of ref document: EP

Representative=s name: REITSTOETTER, KINZEBACH & PARTNER (GBR), 81679 MUE